Endovascular Therapy Eases Post-Thrombotic Syndrome but Increases Bleeding

Post-thrombotic syndrome is a frequent and debilitating complication of deep-vein thrombosis that often leaves patients with chronic limb pain, swelling, and severely impaired quality of life [1]. For patients with advanced disease driven by chronic iliac vein obstruction, standard conservative management frequently falls short, prompting growing interest in catheter-based interventions [2, 3]. While early observational data have suggested that endovascular therapy might relieve venous outflow obstruction and mitigate symptoms, rigorous randomized trial data have been lacking [4]. Furthermore, balancing the potential benefits of these procedures against the bleeding risks of the necessary antithrombotic regimens remains a persistent clinical challenge [5]. A new randomized trial now offers much-needed clarity on the efficacy and safety of endovascular interventions for this difficult-to-treat population, providing physicians with concrete data to guide treatment decisions.